Proterixbio
1 Fortune Blvd
Billerica
Massachusetts
01821
United States
2 articles with Proterixbio
-
ProterixBio announces commercial availability of a semi-quantitative COVID-19 antibody test
9/29/2020
ProterixBio, Inc. announced today commercial availability of the SARS-CoV-2 (RBD) IgG Antibody test, a semi-quantitative COVID-19 serology assay.
-
ProterixBio licenses COVID-19 serology test from Massachusetts General Hospital
7/1/2020
ProterixBio, Inc. today announced completing a licensing agreement with the Massachusetts General Hospital for a COVID-19 serology assay. The assay was developed and validated by researchers at the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University which is a joint vent